By reformulating existing ICS with its proprietary functional excipient, Aquilon Pharma makes ICS soluble in water
Inhaled corticosteroids (ICS) are the basic treatment option for suppressing airway inflammation.
ICS can be delivered via several types of devices, but it is not commonly delivered via Soft Mist Inhalation.
Aquilon Pharma is currently the ONLY development company capable of formulating an Ultra Low Dose Budesonide for lung delivery through Soft Mist Inhaler.
Aquilon Pharma’s AQ001M formulation is the key.